David Blaszczak

David Blaszczak brings over 25 years of healthcare experience across both the public and private sectors, with a focus on pharmaceuticals, medical technology, and healthcare policy. He has advised C-suite executives and boards of leading healthcare companies

on market access, reimbursement strategy, regulatory trends, payer contracting, and growth strategy.

David began his career at the U.S. Department of Health and Human Services and the Centers for Medicare & Medicaid Services (CMS), contributing to major Medicare and Medicaid payment policies and serving as a liaison to Congress and key healthcare stakeholders.

He was also selected as an external advisor to the FDA and CMS to improve collaboration on product approval, payment, and coverage decisions.

In the private sector, David has worked as a consultant supporting investors, med tech firms, and pharmaceutical companies with market access and pricing strategy, regulatory insight, reimbursement trends, and strategic planning. He has led advisory practices

for healthcare consulting firms, managed diligence projects for private equity clients, and built launch strategies for device and drug manufacturers and negotiated reimbursement and coverage contracts among payers.

David is a recognized expert in healthcare delivery and reimbursement, frequently invited to speak at industry and academic events, including Harvard Business School, Yale School of Medicine, and Wharton.